Compare TPC & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPC | TXG |
|---|---|---|
| Founded | 1894 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | General Bldg Contractors - Nonresidential Bldgs | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.6B |
| IPO Year | 2003 | 2019 |
| Metric | TPC | TXG |
|---|---|---|
| Price | $71.74 | $28.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | ★ $86.00 | $20.25 |
| AVG Volume (30 Days) | 413.2K | ★ 2.9M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | ★ 148.24 | 76.97 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $5,543,039,000.00 | $245,893,000.00 |
| Revenue This Year | $15.37 | N/A |
| Revenue Next Year | $9.99 | $7.33 |
| P/E Ratio | $143.17 | ★ N/A |
| Revenue Growth | 28.11 | ★ 68.06 |
| 52 Week Low | $41.16 | $10.17 |
| 52 Week High | $100.00 | $35.65 |
| Indicator | TPC | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 57.32 |
| Support Level | $66.91 | $16.11 |
| Resistance Level | $76.62 | $35.65 |
| Average True Range (ATR) | 3.06 | 2.32 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 60.33 | 46.45 |
Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically it derives key revenue from the United States.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).